Zonal characterization and differential trilineage potentials of equine intrasynovial deep digital flexor tendon-derived cells

• Published in: BMC veterinary research Vol. 17; no. 1; p. 138
• Main Authors: Quam, Vivian G, Altmann, Nadine N, Brokken, Matthew T, Durgam, Sushmitha S
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.04.2021; BioMed Central; BMC
• Subjects: Care and treatment; CD29 antigen; CD44 antigen; CD90 antigen; Cell surface; Chondrogenic phenotype; Diseases; Enzymes; Fibroblasts; Flow cytometry; Gene expression; Genotype & phenotype; Health aspects; Horses; Intrasynovial deep digital flexor tendon; Mesenchyme; Morphology; Physiological aspects; Stem cells; Surface markers; Tendon injuries; Tendon-derived cells; Tendons; Trilineage differentiation; Veterinary medicine; Wound healing; United States; Intrasynovial deep digital flexor tendon; Chondrogenic phenotype; Trilineage differentiation; Tendon-derived cells
• ISSN: 1746-6148; 1746-6148
• DOI: 10.1186/s12917-021-02793-1

Intrasynovial deep digital flexor tendon (DDFT) injuries occur frequently and are often implicated in cases of navicular disease with poor outcomes and reinjuries. Cell-based approaches to tendon healing are gaining traction in veterinary medicine and ultimately may contribute to improved DDFT healing in horses. However, a better understanding of the innate cellular characteristics of equine DDFT is necessary for developing improved therapeutic strategies. Additionally, fibrocartilaginous, intrasynovial tendons like the DDFT are common sites of injury and share a poor prognosis across species, offering translational applications of this research. The objective of this study is to isolate and characterize tendon-derived cells (TDC) from intrasynovial DDFT harvested from within the equine forelimb podotrochlear bursa. TDC from the fibrocartilaginous and tendinous zones are separately isolated and assessed. Flow cytometry is performed for mesenchymal stem cell (MSC) surface markers (CD 29, CD 44, CD 90). Basal tenogenic, osteogenic and chondrogenic markers are assessed via quantitative real time-PCR, and standard trilineage differentiation is performed with third passage TDC from the fibrocartilaginous (fTDC) and tendinous (tTDC) zones of DDFT. Low-density plating isolated homogenous TDC populations from both zones. During monolayer passage, both TDC subpopulations exhibited clonogenicity, high in vitro proliferation rate, and fibroblast-like morphology. fTDC and tTDC were positive for MSC surface markers CD90 and CD29 and negative for CD44. There were no significant differences in basal tenogenic, osteogenic or chondrogenic marker expression between zones. While fTDC were largely restricted to chondrogenic differentiation, tTDC underwent osteogenic and chondrogenic differentiation. Both TDC subpopulations displayed weak adipogenic differentiation potentials. TDC at the level of the podotrochlear bursa, that potentially could be targeted for enhancing DDFT injury healing in horses were identified and characterized. Pending further investigation, promoting chondrogenic properties in cells administered exogenously into the intrasynovial space may be beneficial for intrasynovial tendon regeneration.